Fund Holdings — Sanofi

Total Portfolio Value:
$534.04M
Total Bought:
$53.81M
Total Sold:
$2.51M
Net Transaction:
+$51.30M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
MeiraGTx Holdings plc(MGTX)12,197,73712,197,7370$105.63M$164.79M30.86%+$59.16M
Inhibrx Biosciences, Inc.(INBX)1,157,9261,157,9260$77.85M$109.71M20.54%+$31.87M
Novavax, Inc.(NVAX)6,880,4816,880,4810$56.01M$64.81M12.14%+$8.81M
AnaptysBio821,917821,9170$30.38M$55.48M10.39%+$25.09M
Odyssey Therapeutics Inc.01,991,918+1,991,918$0$37.27M6.98%+$37.27M
Agomab Therapeutics NV2,783,0962,783,0960$29.19M$36.12M6.76%+$6.93M
MapLight Therapeutics Inc.912,041912,0410$18.54M$32.69M6.12%+$14.15M
First Tracks Biotherapeutics Inc.0821,917+821,917$0$16.54M3.10%+$16.54M
Immuneering Corp2,708,5592,708,5590$14.27M$13.52M2.53%-$758.4K
Q32 Bio Inc.244,083244,0830$1.57M$3.11M0.58%+$1.54M
Eledon814,9800-814,980$2.51M$0—-$2.51M
Page 1 of 1
Sanofi — 13F Holdings — Q2 2026 | TickerTrail